Back to search
FDAFDA · Food and drugs·Recall number D-1362-2014

Midazolam 0.2 mg/2 mL 0.9% Sodium Chloride syringes, Total dosage: 0.4 mg per 2 mL, Rx Only, Pharmakon Pharmaceuticals, Inc., 14450 Getz Rd, Noblesville, Indiana, NDC 45183-0014-69.

Published June 18, 2014 · Recall initiated: March 26, 2014

Summary

FDA records drug Class I recall D-1362-2014, published June 18, 2014 and initiated March 26, 2014. Recalling firm: Pharmakon Pharmaceuticals; Status: Terminated; Reported quantity: 80 syringes; Lot: Lot #: E1016227C, Exp. 4/21/2014; E0433735C, Exp. 4/20/2014. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Superpotent Drug: Product contains twice the stated amount of midazolam.

What to do

Voluntary: Firm initiated · Telephone

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Pharmakon Pharmaceuticals
Distributor
IN
Lot
Lot #: E1016227C, Exp. 4/21/2014; E0433735C, Exp. 4/20/2014
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Midazolam 0.2 mg/2 mL 0.9% Sodium Chloride syringes, Total dosage: 0.4 mg per 2 mL, Rx Only, Pharmakon Pharmaceuticals, Inc., 14450 Getz Rd, Noblesville, Indiana, NDC 45183-0014-69. recalled?

Yes. FDA published recall D-1362-2014 on June 18, 2014. Reported hazard: Superpotent Drug: Product contains twice the stated amount of midazolam.

What should I do if I have this product?

Voluntary: Firm initiated · Telephone